Preclinical | sciencenewsnet.in

Breaking News

Recycling CFRP waste is a challenge, but we’ve found a way to make it work

Argonne National Laboratory and the University of Illinois Chicago launch the George Crabtree Institute for Discovery and Sustainability

What women want: Female experiences to manage pelvic pain

Predicting Ovarian Cancer Relapse

Octopus Inspires New Suction Mechanism for Robots

Opioid dependence remains high but stable in Scotland, new surveillance report finds

MSU expert: The cicadas are coming

Soil Bacteria Link their Life Strategies to Soil Conditions

Cleveland Clinic Launches New Women’s Comprehensive Health and Research Center

Telemedicine Can Help Change Care for the Better — If We Get the Rules Right

18 Apr, 2024

Hormone therapy could lower risk of immunotherapy-associated myocarditis in women

November 2, 2022 sarah JonasResearch Results

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San Francisco (UCSF) has discovered the underlying cause of gender differences in immunotherapy-associated myocarditis after immune checkpoint inhibitor (ICI) treatment. Their findings point to possible treatment strategies for this side effect, which disproportionately affects female patients.

Dietary supplementation may improve antibiotic-induced GVHD following stem cell transplants

September 29, 2022 sarah JonasResearch Results

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after antibiotic treatment of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and discovered that nutritional supplementation can prevent antibiotic-induced GVHD in preclinical models, according to a study published today in Cell.